Previous 10 | Next 10 |
SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today a clinical trial in collaboration with Duke University in Durham, NC. The Duke Lupu...
SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that Ron Rocca, President and Chief Executive Officer of Exagen, will present at the Will...
Image source: The Motley Fool. Exagen Inc. (NASDAQ: XGN) Q1 2020 Earnings Call May 11, 2020 , 4:30 p.m. ET Operator Continue reading
Exagen Inc. (XGN) Q1 2020 Earnings Conference Call May 11, 2020 04:30 PM ET Company Participants Mark Hazeltine - Senior Vice President of Finance & Corporate Development Ron Rocca - President & Chief Executive Officer Kamal Adawi - Chief Financial Officer Conference C...
The following slide deck was published by Exagen Inc. in conjunction with their 2020 Q1 earnings Read more ...
Exagen (NASDAQ: XGN ): Q1 GAAP EPS of -$0.44 misses by $0.10 . More news on: Exagen Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported financial results for the quarter ended March 31, 2020. First Quarter Highlights:...
SAN DIEGO, April 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic inter...
Image source: The Motley Fool. Exagen Inc. (NASDAQ: XGN) Q4 2019 Earnings Call Mar 25, 2020 , 4:30 p.m. ET Operator Continue reading
Start Time: 16:30 End Time: 17:07 Exagen Inc. (XGN) Q4 2019 Earnings Conference Call March 25, 2020, 16:30 PM ET Company Participants Ron Rocca - President and CEO Kamal Adawi - CFO Mark Hazeltine - SVP of Finance & Corporate Development Conference Call Participants ...
News, Short Squeeze, Breakout and More Instantly...
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2024. First Quarter Highlights: Recognized total revenue of $14.4 million in the ...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on Monday, May 13, 2024. John Aballi, Exagen’s President and Chief Executiv...